Context There is increasing evidence for Müllerian-inhibiting substance (MIS)/anti-Müllerian
hormone (AMH) physiologic activity in the human uterus, so it is relevant to study how …

Objective To determine the relationship between high antimüllerian hormone (AMH) levels
and increased preterm delivery risk in populations of women with polycystic ovary syndrome …

OBJECTIVE: This study determines whether pretreatment levels of müllerian inhibiting
substance/antimüllerian hormone (MIS/AMH) would reflect ovarian response to exogenous …

We performed this updated systematic review and meta-analysis to evaluate anti-Müllerian
hormone levels (AMH) in newborns of mothers with polycystic ovary syndrome (PCOS) …

Research question What are the trends in anti-Müllerian hormone (AMH) concentrations
from pre-conception to the third trimester of pregnancy in women with polycystic ovary …

We sought to determine serum AMH levels in the maternal circulation, and the umbilical
artery and vein, in normal women and women with PCOS, and their neonates at time of …

Introduction Anti-Müllerian hormone (AMH) level has long been considered as a serum
biomarker of ovarian reserve clinically, while emerging data suggest that serum AMH level …

Objective To investigate plasma antimüllerian hormone (AMH) concentration and its relation
to steroid hormone levels in pregnant women with polycystic ovary syndrome (PCOS) and …

Context Antimüllerian hormone (AMH) levels are higher in patients with polycystic ovary
syndrome (PCOS). Accumulating evidence indicates that AMH has an impact on the …

Women with polycystic ovary syndrome (PCOS) tend to have elevated anti-Müllerian
hormone (AMH) levels, which appear to correlate with disease severity and pregnancy …